A Thorough Overview of Current Developments in Imidazole Derivatives for Anticancer Drug Development

Cancer remains a leading cause of mortality worldwide. This necessitates the development of novel, effective therapeutic agents. Nitrogen-containing heterocycles play a vital role in medicinal chemistry. Among them, imidazole and its derivatives have gained attention for their broad biological activities. Recently, imidazolebased compounds have shown promise as anticancer agents by inhibiting kinases, inducing apoptosis, causing cell-cycle arrest, and targeting DNA-associated enzymes. This review analyzes journal studies on imidazole derivatives with anticancer potential, focusing on their synthesis, structure–activity relationships, biological evaluation, and molecular targets. The references provide a scientific foundation for further design and development of imidazole-based anticancer drugs.